Abstract: A system and method for table conversion including converting a table containing text in tabular form to an image, labeling each text area of the image with a bounding box, determining for each bounding box, a position information, a semantic information, and an image information, reconstructing the image into a graph form having a plurality of nodes, wherein each node represents the bounding box of the text areas of the image, inputting at least two nodes into a trained neural network to determine a relative relationship between the at least two nodes, building a knowledge graph using the relative relationship of the at least two nodes, and translating the knowledge graph into machine readable natural language.

Abstract: A wireless communication network receives a first Subscriber Identity Module (SIM) profile from a User Equipment (UE) and authenticates the UE based on the first SIM profile. The network receives a first slice request from the UE and authorizes a first wireless network slice for the UE based on the authentication of the first SIM profile and the first slice request. The network receives a second SIM profile from the UE and authenticates the UE based on the second SIM profile. The network receives a second slice request from the UE and authorizes a second wireless network slice for the UE based on the authentication of the second SIM profile and the second slice request. The network wirelessly exchanges first slice data with the UE over the first wireless network slice, and simultaneously, exchanges second slice data with the UE over the second wireless network slice.

Abstract: A communication method includes determining that content of a to-be-sent second data packet is the same as content of a first data packet, and sending repetition indication information. The second data packet follows the first data packet. The repetition indication information is useable to indicate that the second data packet repeats a previous data packet.

Abstract: Provided is a method for synthesizing a chiral amine compound. A transaminase is used to transaminate a ketone substrate under the action of an amino donor, to obtain the chiral amine compound; and the conserved amino acid sequence region of the transaminase at least includes a region 1 (MAGLWCVN) and a region 2 (YNTFFKT). With the transaminase with the specific conserved amino acid sequence region to synthesize a large sterically hindered chiral amine, the enzyme catalytic reaction volume is small, the synthesizing route is short, the product yield is high, a high-cost noble metal is not required for catalysis under the synthesizing conditions, three wastes are reduced, and the production cost is saved.

Abstract: Uplink control channel group and cross-carrier scheduling is disclosed for cooperative communications of a virtual UE. In an aspect, a UE reports a cooperative configuration with member UEs of a virtual UE and reports associations between a plurality of component carriers (CCs) allocated to a cell group and each member UE of the virtual UE. The UE may then receive an uplink control transmission configuration message dividing each member UE into an assigned uplink control transmission group and assign one or more component CCs into one or more CC sets, wherein each CC set is assigned to each uplink control transmission group. The UE may receive an uplink scheduling message from a serving base station, wherein the uplink scheduling message includes an uplink schedule for CCs within the CC set assigned to an uplink control transmission group associated with the UE. Other aspects and features are also claimed and described.

Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may transmit a beam applicability report that indicates beam applicability information corresponding to one or more physical channels for a UE cooperation operation. The UE may communicate with at least one wireless communication device in the UE cooperation operation based at least in part on the beam applicability information. Numerous other aspects are described.

Abstract: A display panel includes a plurality of sub-panels tiled in sequence along a first direction. The sub-panels have a first edge and a second edge in the first direction. The sub-panels include a column of first pixels closest to the first edge, a column of second pixels closest to the second edge, and a plurality of columns of third pixels between the column of first pixels and the column of second pixels. A sum of a distance between effective display bodies in the first pixels and the first edge and a distance between effective display bodies in the second pixels and the second edge is smaller than a spacing between effective display bodies in two adjacent columns of the third pixels.

Abstract: Method for assisting in a travel arrangement includes receiving, by a mobile terminal, a travel instruction, the travel instruction including a destination; obtaining vehicle information of a vehicle corresponding to the mobile terminal; obtaining destination information of the destination; and assisting in the travel arrangement based on at least one of the vehicle information or the destination information.

Abstract: Aspects herein provide a system, media, and methods for a mobile edge computer that renders extended reality (XR) in support of a local user device, via a local network. The mobile edge computer can continue to provide updated XR renderings in near real-time when user position data remains within a particular viewing angle, without requesting updated content or rendering assistance from a remote application. When user position data is determined to be outside of the viewing angle, then the mobile edge computer may request additional content from the remote application.

Abstract: Methods, systems, and devices for wireless communication are described. A user equipment (UE) may transmit, to a base station, a capability report that includes an indication of a maximum number of reference signal resources within a transmission time interval (TTI) for which the UE supports channel state information (CSI) reporting. The maximum number of reference signal resources may be based on a capability for supporting joint CSI reporting for both a downlink and an uplink. The UE may receive, from the base station, a report configuration in response to the capability report. Subsequently, the base station may transmit reference signals to the UE, which the UE may use to determine CSI for both the downlink and the uplink. The UE may then transmit, to the base station, a CSI report including the CSI for both the downlink and the uplink, in accordance with the report configuration.

Abstract: MLX1034 is from Polaribacter sp. Q13, and has the amino acid sequence of the 1,3/1,4-xylanase MLX1034 is listed in SEQ ID NO.1; a nucleotide sequence of the gene is listed in SEQ ID NO.2; the 1,3/1,4-xylanase MLX1034 in the invention is capable of efficiently and specifically degrading 1,3/1,4-xylan and producing xylooligosaccharides with DP values above one; in addition, the physical and chemical properties of the 1,3/1,4-xylanase MLX1034 are stable enough to hydrolyze 1,3/1,4-xylan at room temperature; the 1,3/1,4-xylanase MLX1034 is suitable for the industrial production of red algal xylooligosaccharides at low energy costs.

Abstract: A joint movement analysis system, comprising: a plurality of actual markers positioned around a joint, wherein space positions of the actual markers track space movement of virtual marker points that are set at anatomical bony landmark positions of the joint; an optical tracking device that senses the space positions of the actual markers so as to obtain a space movement data of the actual markers; a data collection device that collects the space movement data of the actual markers and a relative space position data of the virtual marker points with respect to the actual markers; and a data analyzing device that obtains a space movement data of the virtual marker points from the space movement data of the actual markers, and simulates and analyzes a movement of the bony structure of the joint according to the space movement data of the virtual marker points.

Abstract: A knee joint dynamic evaluation method for diagnosing human joint diseases by tracking motions of the knee joint includes constructing an evaluation model including a first angular difference threshold ?1, a second angular difference threshold ?2, and an anterior-posterior displacement difference threshold ?; synchronously collecting a single set of three-dimensional and six-degree-of-freedom movement data of a left knee joint and that of a right knee joint with devices; comparing the three-dimensional and six-degree-of-freedom movement data between the left and right knee joints with a data analyzing device, and calculating differences of the flexion and extension angles, the medial and lateral tilt angles, the medial and lateral rotation angles, and the anterior-posterior displacement movement values of the two sets of movement data; inputting the differences into the evaluation model to obtain the corresponding grading system, which will output the first, second, third, or fourth evaluation level.

Abstract: Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a neuron, or combinations thereof. The method comprises contacting the lesioned mature neuron with an effective amount of an inhibitor of PTEN and an effective amount of an inhibitor of SOCS3 to thereby promote survival and/or regeneration and/or compensatory outgrowth of the neuron. Therapeutic methods of treatment of a subject with a neuronal lesion by administration of a therapeutically effective amount of an inhibitor of PTEN and a therapeutically effective amount of an inhibitor of SOCS3, are also disclosed, as are pharmaceutical compositions and devices for use in the methods.

Abstract: The invention discloses a compound with the following formula (I), wherein, K is selected from: cycloalkyl and halo alkyl or N—R6. The invention also discloses a tyrosine kinase inhibitor containing the above compound and the use of the compound in preparing drugs for treating cancers. The tyrosine kinase inhibitor of the invention can inhibit the bioactivity of multiple signal conduction kinases such as C-MET, VEGF, KDR, etc., can effectively inhibit cell proliferation and has favorable therapeutic effects on various diseases such as cancer. In particular, the present invention has significant therapeutic effects especially on lung cancer, gastric cancer, ovarian cancer, malignant glioma, etc., and has a very broad application prospect.

Abstract: The invention discloses a compound with the general formula of (I), wherein, K is selected from: naphthene alkyl and haloalkane alkyl or N—R6. The invention also discloses a tyrosine kinase inhibitor containing the above compound and the application of the compound in preparing drugs for treating cancers. The tyrosine kinase inhibitor of the invention inhibits the bioactivity of multiple signal conduction kinases such as C-MET, VEGF, KDR, etc., it can effectively inhibit cell proliferation and has favorable therapeutic effects on various diseases such as cancer, it has significant therapeutic effects especially on lung cancer, gastric cancer, ovarian cancer, malignant glioma, etc., and it has a very broad application prospect.

Abstract: Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a neuron, or combinations thereof. The method comprises contacting the lesioned mature neuron with an effective amount of an inhibitor of PTEN and an effective amount of an inhibitor of SOCS3 to thereby promote survival and/or regeneration and/or compensatory outgrowth of the neuron. Therapeutic methods of treatment of a subject with a neuronal lesion by administration of a therapeutically effective amount of an inhibitor of PTEN and a therapeutically effective amount of an inhibitor of SOCS3, are also disclosed, as are pharmaceutical compositions and devices for use in the methods.

Abstract: Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a neuron, or combinations thereof. The method comprises contacting the lesioned mature neuron with an effective amount of an inhibitor of PTEN and an effective amount of an inhibitor of SOCS3 to thereby promote survival and/or regeneration and/or compensatory outgrowth of the neuron. Therapeutic methods of treatment of a subject with a neuronal lesion by administration of a therapeutically effective amount of an inhibitor of PTEN and a therapeutically effective amount of an inhibitor of SOCS3, are also disclosed, as are pharmaceutical compositions and devices for use in the methods.

Abstract: A joint movement analysis system is provided in the present invention, comprising a calibrating device which is used for setting connections between actual marker points around a joint and virtual marker points at the anatomical bony landmark positions of the joint to track the space movement of the joint; an optical tracking device which is used for sensing the space position of the actual marker points so as to obtain the space movement data of the actual marker points; a data collection device which is used for collecting the space movement data of the actual marker points and the space relative position data of the virtual marker points with respect to the actual marker points; a data analyzing device which is used for obtaining the space movement data of the virtual marker points by optimization operating of the movement data of the actual marker points, and simulating and analyzing the movement condition of the joint bony structure according to the space movement data of the virtual marker points.

Abstract: Disclosed herein is a method of promoting sustained survival, sustained regeneration, in a lesioned mature neuron, sustained compensatory outgrowth in a neuron, or combinations thereof. The method comprises contacting the lesioned mature neuron with an effective amount of an inhibitor of PTEN and an effective amount of an inhibitor of SOCS3 to thereby promote survival and/or regeneration and/or compensatory outgrowth of the neuron. Therapeutic methods of treatment of a subject with a neuronal lesion by administration of a therapeutically effective amount of an inhibitor of PTEN and a therapeutically effective amount of an inhibitor of SOCS3, are also disclosed, as are pharmaceutical compositions and devices for use in the methods.